Please provide your email address to receive an email when new articles are posted on . Gildeuretinol, an oral therapy for Stargardt disease, received rare pediatric disease and fast track ...
The Tolerability and Effects of ALK-001 on Stargardt diseasE (TEASE) studies consist of four independent clinical studies of oral gildeuretinol (ALK-001) in Stargardt disease, denoted as TEASE-1, ...
?A new drug which could help prevent sight loss caused by a currently untreatable condition is being trialled for the first time in the UK.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results